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ABSTRACT 
The canonical model of transcriptional regulation in prokaryotes restricted 
binding site locations to promoter regions and suggested that the binding sequences 
serve as the main determinants of binding. In this dissertation, I challenge these 
assumptions. 
As a member of the TB Systems Biology Consortium, I analyzed and validated 
ChIP-Seq and microarray experiments for over 100 transcription factors (TFs). In 
order to study the transcriptional functions of predicted binding sites, I integrated 
binding and expression data and assigned potential regulatory roles to 20% of the 
binding sites. Stronger binding sites were more often associated with regulation 
than weaker sites, suggesting a correlation between binding strength and regulatory 
impact. Seventy-six percent of the sites fell into annotated coding regions and a 
significant proportion was assigned to regulatory functions. 
To study the importance of binding sequences, I compared experimental 
sites with computational motif predictions. Although a conservative binding motif 
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was found for most TFs, only a fraction of the observed motifs appeared bound in 
the experiment. Some low-affinity binding sites appeared occupied by the 
corresponding TF while many high-affinity binding sites were not. Interestingly, I 
found exactly the same nucleotide sequences (up to 15 residues long) bound in one 
area of the genome but not bound in another area, pointing to DNA accessibility as 
an important factor for in vivo binding. 
To investigate the evolutionary conservation of binding-site occupancy, 
sequence, and transcriptional impact, I analyzed ChIP-Seq and expression 
experiments for five conserved TFs for two-to-four Mycobacterial relatives. 
The regulon composition showed significantly less conservation than 
expected from the overall gene conservation level across Mycobacteria. Despite 
expectations, sequence conservation did not serve as a good indicator of whether or 
not a computationally predicted motif was bound experimentally; and in some 
cases, a fully conserved motif was bound in one relative but not in the other. 
Conservation of genic binding sites was higher than expected from the random 
model, adding to the evidence that at least some genic sites are functional. 
Understanding the evolutionary story of binding sites allowed me to explain unusual 
site configurations, some of which indicated a role for DNA looping.  
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Chapter 1. Regulatory networks of M. tuberculosis and E. coli: Analysis and 
validation of ChIP-Seq protocol and data. 
1.1. Introduction 
Chromatin immunoprecipitation followed by sequencing (ChIP-Seq) provides the 
ability to globally map transcription factor (TF) binding sites in vivo. Despite the power 
of ChIP-Seq to rapidly and comprehensively identify regulatory interactions, applications 
of the technique have been largely restricted to complex eukaryotes. The small size of 
microbe genomes makes ChIP-Seq even more powerful in these organisms. 
Complete ChIP-Seq analysis involves many steps. Most important ones – 
detection of true binding peaks, TF binding motif, and TF target genes – are discussed in 
Chapters 1, 2, and 3 of this work. 
To systematically map transcription factor binding sites, members of the Galagan 
Lab developed a ChIP-Seq protocol optimized for global profiling of small genomes. Dr. 
Sang Tae Park and Dr. Mathew Peterson, respectively, are main developers of 
experimental and computational parts of the protocol [1]. We successfully applied our 
protocol to 133 TFs in M. tuberculosis and 17 TFs in E. coli yielding 11266 and 3108 
binding sites, respectively (data summarized in Appendix, Tables 3 and 4). 
This chapter describes my efforts to validate both parts of the protocol when 
applied to M. tuberculosis and E. coli and refine the computational part of the ChIP-Seq 
pipeline. 
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1.2. M. tuberculosis and E. coli – benefits of global ChIP-Seq mapping 
Mycobacterium tuberculosis (MTB) is a highly successful human pathogen that 
can survive within the human body for long periods of time in a latent state. MTB 
primarily resides within human macrophages and persists within the cells despite low pH 
and absence of oxygen (state called hypoxia). MTB also shifts to lipids, including 
cholesterol, as a primary nutrient [1–4]. Lipid catabolism is, in turn, linked to the 
biosynthesis of lipids that serve as an energy depot, factors associated with virulence and 
immunomodulation, and components of the unique and complex cell wall of MTB [5–
7].The transcriptional mechanism underlying the MTB persistence in the host are poorly 
understood [8,9]; however, KstR [10,11] and DosR [12] are two major TFs essential for 
hypoxic and lipid adaptations, respectively. 
Escherichia coli is a well-studied bacterium used as a reference in many areas of 
research including studies of fundamental mechanisms of bacterial gene regulation 
[13,14]. Its transcriptional regulatory network is crucial in attempts to engineer the 
bacterium for a variety of industrial, biotechnological, and environmental applications. 
For biofuel production in particular, understanding of transcriptional mechanisms 
underlying E. coli stress responses plays an important role in the development of strains 
with tolerance to specific chemicals and stresses arising from bioprocess conditions [15–
17]. Despite the large number of TFs studied in E. coli, direct regulatory interactions for 
most TFs are known only for a small number of loci. Existing global studies of regulons 
typically involved the analysis of differential gene regulation which cannot distinguish 
direct from indirect regulatory effects. 
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1.3. ChIP-Seq method overview 
ChIP-Seq is a well-established method for identifying binding sites for DNA-
binding proteins [18–20]. This method involves (1) cross-linkage of DNA-binding 
proteins to DNA, (2) DNA shearing, (3) immunoprecipitation of DNA fragments bound 
by a protein of interest, and (4) sequencing of precipitated DNA fragments. Resulting 
sequencing reads are aligned to the corresponding genome, and genome areas bound by 
the protein of interest are expected to be over-represented with aligned reads. 
Ideally, only genomic regions bound by the protein of interest would display read 
coverage. In practice, some DNA fragments are isolated and sequenced non-specifically, 
resulting in a background coverage of reads aligned across the genome sequence. To 
assess this background coverage, some control experiments are typically used. Binding 
sites for the protein of interest are regions along the genome characterized by 
significantly greater read coverage in the protein ChIP-Seq experiment than in the 
background coverage. ChIP-Seq also produces a strand specific signature of enrichment 
that can be used to identify true binding peaks. 
DNA binding proteins, especially transcription factors, typically bind to short 
DNA sequences (on the order of 15 nucleotides or less). Enriched peaks, however, 
typically span a region of several hundred base pairs as a consequence of the larger 
fragment size generated during ChIP (typically around 250 nucleotides). Moreover, when 
multiple closely spaced binding sites exist in a particular location, the read coverage for 
these sites can merge into a single broad enriched region. 
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1.4. Existing ChIP-Seq tools overview 
Numerous algorithms and software programs have been developed for ChIP-Seq 
analysis. These have been reviewed in a number of articles [21–24]. Different software 
packages provide slightly different options and therefore slightly different solutions to the 
problem. Importantly, most of them are tailored for work with large eukaryotic genomes 
and are not optimized for smaller microbial genomes. The small size of microbes 
increases the mean coverage of an experiment from a couple of reads per nucleotide to 
hundreds. As a result, binding sites can be called with higher accuracy [25] and various 
ChIP-Seq artifacts can be detected and filtered out. Figure 5 provides examples of ChIP-
Seq peaks obtained for small genomes. 
Most common ChIP-Seq software takes raw sequence data and outputs a set of 
predicted enriched regions. Known peak-callers include FindPeaks [26], CisGenome 
[27], PeakSeq [28], HPeak [29], PeakAnalyzer [30], ChIPpeakAnno [31], PeakRanger 
[32], MACS [33], ChIPseeqer [34], CSAR [35], CentriMO [36], SISSRs [37], DROMPA 
[38], and jMOSAiCS [39]. All of these packages are optimized for ChIP-Seq on complex 
eukaryotic genomes only. 
1.5. Experimental ChIP-Seq protocol developed at the Galagan Lab 
An overview of our experimental ChIP-Seq pipeline is shown in Figure 1. In 
MTB and relatives, we performed ChIP-Seq using FLAG-tagged transcription factors 
episomally expressed under control of a mycobacterial tetracycline-inducible promoter 
[40-42], a method previously validated for ChIP-Seq in other systems [43,44]. In E. coli, 
we use the same inducible system with a LAC-promoter. 
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The inducible promoter system allows us to study all the regulators of an 
organism in a standard and reproducible reference state without a priori knowledge of the 
conditions that normally induce their expression. From a technical point of view, this 
system produces a characteristic enrichment pattern corresponding to the induction of the 
TF of interest called watermark. A watermark is a uniform enrichment along the induced 
TF gene at least 5 times above the mean coverage. Its presence verifies that the ChIP part 
of the protocol was carried out correctly and prevents TF mix-ups. The latter can be a 
very big issue for large-scale studies. 
 
Figure 1. Overview of ChIP-Seq experimental pipeline. 
1.6. Computational ChIP-Seq protocol developed at the Galagan lab 
An overview of our computational ChIP-Seq pipeline is shown in Figure 2. 
Sequence reads are mapped to version two of the M. tuberculosis genome using MAQ71. 
Regions of enrichment along the genome are identified using a lognormal distribution. 
Coverage at each position is scored against the distribution and positions with a p-value 
of 0.01 or lower are called as enriched. Since TF binding is expected to result in 
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contiguous regions of enrichment, only regions of 100 nucleotides or longer are included 
in further analysis. A cross-correlation filter is then applied to the resulting regions to 
identify those that have the expected signature of transcription binding in ChIP-Seq 
experiments, identified by a shift between peaks in the forward and reverse strands. 
Regions with a shift of less than 60 nucleotides are removed from further analysis. Note 
that such a filter is not effective in ChIP-Seq experiments with low coverage as the shift 
length is not easily detected. 
Shift-filtered regions are then compared against wild-type experiments in order to 
remove enriched regions caused by sequencing artifacts. 
 
Figure 2. Overview of ChIP-Seq computational pipeline. 
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I ran the E. coli data generated at Galagan Lab through our pipeline (named 
SPAT) and other three most popular peak callers. I compared the ability of these 4 
programs to detect experimentally validated binding sites reported in EcoCyc [45]. Our 
program is the only one that located all 43 known sites for 3 TFs. I obtain the same result 
for 72 MTB sites previously reported for KstR and DosR. 
 
Figure 3. Performance of 4 peak callers on the validated E. coli binding sites. 
1.7. ChIP-Seq validation 
Considering the experimental ChIP-Seq protocol we implemented includes 
overexpression of the TF of interest, I focus on validating the physiological nature of the 
binding that we observe. In particular, I want to confirm that the binding does not reflect 
random attachment of protein to DNA as a result of induced expression or artificial 
tagging. 
The following MTB data shows that we detect sequence specific binding: 
• A good binding motif is predicted for 43 of 58 TFs that have more than 20 
binding regions. Of those 43, 35 TFs have a particularly strong motif. TF binding motifs 
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are predicted using MEME [46,47] and the measure of the motif strength is the predicted 
motif e-value. I discuss TF binding motifs further in Chapter 3. 
• Genes associated with weak KstR binding are non-randomly associated with 
expected gene functions, consistent with the known regulatory role of KstR. 
• Binding sites increase in enrichment with increasing induction levels of TF, in 
both presence and absence of oxygen (normoxia and hypoxia), as would be expected for 
natural binding sites. Titration ChIP-Seq experiments of KstR in normoxia is shown in 
Figure 14. 
• We carried out biological replicates of ChIP-Seq on 9 transcription factors and 
compared the resulting coverage. The binding sites we detect are highly reproducible in 
both enrichment and location (Figure 4). 
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Figure 4. ChIP-Seq binding shows high reproducibility in peak height. For each TF, a scatter plot displays the 
correlation between read coverage for all regions identified in either biological replicate. Correlation coefficient 
(R2) is shown in the legend of each graph. 
1.8. ChIP-Seq under different physiological conditions 
Interestingly, the ChIP-Seq profile is highly reproducible under different cellular 
conditions (Figure 5). To perform ChIP-Seq on many TFs, we selected a reference cell 
culture condition – normoxia. Then, we tested binding reproducibility under different 
physiological condition, hypoxia, for 11 TFs. Some of the tested TFs are known to 
respond to hypoxia (KstR, Lsr2, and EspR). 
  
10 
 
Figure 5. Comparison of ChIP-Seq enrichment between normoxia and hypoxia conditions. For each TF, a 
scatter plot displays the correlation between read coverage for all regions identified in either hypoxia or 
normoxia. To the right of each scatter plot are images of raw coverage for selected binding sites. The three 
binding sites that show the most substantial difference in affinity between hypoxia and normoxia are colored in 
red in the scatter plots. 
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In over 4000 predicted binding sites for 11 TFs we observe only a handful of sites 
that show marked differences in binding between hypoxia and normoxia. Note the three 
binding sites showing the most substantial differences between conditions (highlighted in 
red in Figure 5). All three binding events are autobinding sites in the promoters of TFs 
that are differentially expressed in hypoxia, and in all three cases, affinity increased in 
hypoxia. We are planning further experimental validation of this observation. 
1.9. Hot and cold genomic areas 
We observe that certain regions show statistical enrichment in nearly all ChIP-Seq 
experiments regardless of the ChIPed transcription factor. We call these regions “hot”. 
I studied this phenomenon in M. tuberculosis as we accumulated the largest ChIP-
Seq dataset for that organism. After we apply the above-described protocol, we detect 
17313 regions for 133 TFs. For each binding region mode, I find the number of other TFs 
having a region mode within 100 nucleotides. Surprisingly, 35% of all regions are “hot”, 
i.e. have at least one other TF potentially binding at the same location. In order to 
compare this observation to an expectation estimate, I randomly sample from all 
computationally predicted binding instances (see Chapter 3 for more details) and find, on 
average, 9% of randomized motifs potentially co-bind with at least one other TF (Figure 
6, panels A-B). 
We expect that genomic areas bound in a large number of distinct ChIP-Seq 
experiments reflect non-specific binding. I find that these genomic areas tend to be highly 
AT-rich and ChIP-Seq signatures in these locations are wider (our detection method is 
independent of region width). 
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Interestingly, these areas are enriched for particular TFs and their combinations 
(Figure 6, panels C-D). Lsr2 (Rv3597c), a known histone-like or nucleoid-associated 
protein [48-51], explains a larger number of these non-specific binding events. Lsr2 alters 
chromatin structure through DNA looping and thus likely modulates binding of other 
factors. Nucleoid-associated proteins are discussed further in Chapter 2. 
 
Figure 6. Regions showing statistical enrichment for more than one TF. A. Percent of TB regions having 
additional TFs bound in the same location. If there is at least one additional TF bound, we call the region “hot”. 
B. Percent of randomized motifs overlapping. C. The list of TFs that explain at least 10% of “hot” TB regions. 
D. The list of pairs of TFs that explain at least 20% of “hot” TB regions. 
I filter out all regions with more than one additional TF binding it (Figure 7, panel 
B); however, we still observe areas of the genome that are unusually enriched or depleted 
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of binding sites (Figure 7). “Hot” areas are potential regulatory module while “cold” 
areas could signify genomic regions with restricted accessibility (for example, by Lsr2). 
Any potential function of these genomic areas is hard to prove and should be 
explored experimentally. If “hot” areas represent complex regulatory modules, point 
mutations of these sites should disrupt transcription of potential targets (Figure 7, panel 
C). If “cold” areas represent inaccessible genomic areas, an introduction of a strong motif 
for a well-studied TF should not produce a binding signature (Figure 7, panel A). Such 
areas were previously reported and discussed in eukaryotes in the context of histone-
driven DNA organization. It was not previously reported in prokaryotes. 
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Figure 7. Areas of the genome unusually enriched for (hot) or depleted of (cold) binding. Scatter plot: The size of 
the dot is inversely correlated with the number of windows (2000nt wide) characterized by given numbers of 
experimental (Y-axis) and computational (X-axis) estimates of bound TFs. A. Example of a cold area: Blue bars 
indicate strong predicted motifs. B. Example of a hot region: Enrichment is located for 63 different TFs and 
regions centers are located in exactly the same position. C. Example of a hot area: Enrichment is located for 32 
different TFs and regions centers are scattered within relatively large loci. 
1.10. Conclusion 
I introduce a new experimental and computational ChIP-Seq pipeline developed 
at the Galagan Lab and demonstrate its validity. I discuss previously unreported ChIP-
Seq artifact where exactly the same genome position is predicted to be bound by multiple 
TFs. It should be taken into account when analyzing the ChIP-Seq data. The source of 
this artifact is yet unknown. I also note that even after filtering out the artifact, 
prokaryotes contain genomic areas unusually enriched for or depleted of binding. These 
areas might have a regulatory role. Such hot and cold areas would not be surprising for 
eukaryotic genomes considering the role of histones in DNA organization [53]. However, 
the role of accessibility and histone-like proteins in prokaryotes is often underestimated. 
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Chapter 2. Assignment of regulatory targets to transcription factor binding 
sites and assessment of their potential function. 
2.1. Introduction 
Chapter 1 describes a novel high-throughput method of TF binding site detection. 
Once we locate the binding sites and establish the high quality of the data, we explore 
potential gene targets of investigated TFs. The canonical model in prokaryotes suggests 
that binding in the proximal promoter region of a gene implies an interaction between the 
TF and that gene. However, even this simple association has exceptions and is 
complicated by the common occurrence of pairs of genes transcribed from a divergent 
promoter (in which case the site could modulate either or both genes or neither). But the 
task of assigning binding sites to regulation has become far more challenging given the 
diversity of binding site locations discovered by ChIP mapping, as described next [54]. 
2.2. Canonical model of transcriptional regulation 
In prokaryotes, the most common mechanism of transcriptional regulation is 
through interaction between a transcription factor bound close to a promoter and an 
RNA-polymerase molecule. In case of an activator, binding sites are usually detected 
closely upstream or overlapping their target promoter regions. In this case, the 
transcription factor is either interacting with the flexible subunit of the RNA-polymerase 
or promotes the sigma-factor binding. In case of a repressor, binding sites are normally 
found overlapping the promoter region or immediately downstream of it. This way, the 
transcription factor sterically prevents the polymerase from binding or stops the 
transcription elongation [55,56]. 
  
16 
A lot of studies a priori assume the above-described model and only report 
binding sites located near the target gene start while dismissing anything else as a false 
site. For example, when a study is driven by the co-expression data, microarray 
experiments provide a list of potential target genes based on their expression levels as a 
result of a perturbation of the transcription factor of interest. Then, computational 
methods of the binding site prediction locate a common binding motif that would explain 
the co-expression. The efficiency of such prediction depends on the length of input 
fragments as well as the strength and frequency of the signal. Most studies limit their 
search to intergenic regions only [57,59] or some fixed number of nucleotides upstream 
of the translational start site [58,60]. Such assumptions are made even in those studies 
where the binding site motif is known beforehand [59,60] to reduce the number of false 
positives. 
A transcription factor bound at a distance can also influence the transcription of a 
gene. Two mechanisms of such interactions were proposed. (1) DNA can act as a 
mediator between a distal binding site and the target promoter. In tracking model, a 
transcription factor attaches to its binding site and then tracks along the DNA to contact 
the RNA-polymerase. For example, for bacteriophage T4 late genes, the DNA 
polymerase accessory proteins act as transcription activators due to their ability to slide 
along the DNA even if their binding site (nick in the non-transcribed strand) is located 
thousands nucleotides away [61]. (2) The looping model suggests transcription factor 
stays bound to its binding site and directly interacts with its target promoter area through 
DNA bending. 
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To determine the mechanism of transcriptional regulation, it is essential to 
correctly map transcription and translation start sites (TSS) as well as promoter regions. 
For M. tuberculosis, information on promoters and transcription starts is limited and 
mostly obtained through computational methods [62,63]. For E. coli, much more 
experimental data is available. It helped to locate errors in the genomic annotation and in 
some cases indicated the presence of transcription start sites within coding regions which 
corresponded to antisense or alternative transcription sites [64-68]. 
Keeping in mind both the variety of mechanisms for the transcription factor 
regulation and possible genome annotation incompleteness, I suggest using stringent 
statistical method which takes into account the way I assign target genes to binding sites 
through multiple testing correction, rather than limiting the analysis by using stringent 
thresholds that excludes possibility of non-canonical regulation. 
2.3. Overview of experimentally demonstrated cases of unusual 
transcriptional regulation 
It is hard to distinguish between different mechanisms of the transcription factor 
regulation experimentally; however, various distal binding sites were proven to be 
essential for regulation of their target genes. 
I list a few examples of in vivo binding sites located in a non-canonical position 
relative to the gene start: 
 In Escherichia coli, the deo operon, encoding nucleoside catabolizing enzymes, is 
repressed through three deoR binding sites. These sites are located upstream of deo 
operon at -8 (P2 operator), -606 (P1 operator), and -885. Binding sites P1 and P2 are 
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essential for the transcription factor function. Constructs with P1 placed 1 to 5 kb 
downstream of the P2 show efficient repression. The requirement for the cooperative 
action of two binding sites is their presence on the same DNA molecule [69]. 
 In Escherichia coli, lac repressor regulates lac operon through three binding sites: 
high-affinity site immediately downstream of the promoter (O1) and two low-affinity 
binding sites 92 nucleotides upstream (O3) and 401 nucleotides downstream (O2) of O1. 
Either O2 or O3 in combination with O1 is required for efficient repression. The repression 
happens due to formation of stable loops and is especially important at lower 
concentrations of lac repressor. High concentrations of repressor seem to abolish loop 
formation and favor single occupancy of multiple operator sites [70]. 
 A similar example in B. subtilis, ahrC represses argCAEBD-cpa-argF operon 
binding at two sites: argCo1 upstream (-60 to -9) and argCo2 within the coding region 
(+120) of argC. In vitro, the second binding site is bound only at high concentrations of 
the transcription factor (i.e. the binding site within coding region has lower binding 
affinity). However, in vivo, argCo2 is essential for high levels of repression [71]. 
 In Escherichia coli, Rns protein exhibits auto-activation instead of repression 
through a similar combination of binding sites as above. One binding site is located at -
227, while two additional binding sites are found at +43 and +82 [72]. Remarkably, the 
absence of the most downstream binding site completely abolishes activation. 
The DNA looping mechanism was demonstrated in detail for the glnALG operon 
regulation [73-75]. 
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 In Escherichia coli, glnALG operon is regulated by NRI (also known as glnG or 
ntrC) protein through five binding sites located at positions from -259 to -60. Binding 
sites 1 and 2 are strong, while sites 3, 4, and 5 are weak. Binding sites 1 and 2 – located 
150-100 nucleotides upstream from the promoter is essential for operon activation in 
nitrogen-limiting medium. Re-location of the regulatory region 3.1 kb upstream (high 
affinity sites only) or 3 kb downstream of the promoter (low affinity sites only) does not 
affect the activation of transcription at appropriate NRI concentration levels. Moreover, 
the promoter and the enhancer regions put on two singly linked plasmids are able to 
interact. If two DNA molecules are decatenated, or if binding sites are placed closer to 
the promoter, the interaction is disrupted, which indicates that DNA looping mediates the 
interaction. 
A regulatory element does not always have a single target gene, and it is wrong to 
assume that the closest promoter is always the only one being influenced. 
 In Bacillus subtilis, RocR protein regulates rocG through a binding site located 
about 100 nucleotides downstream of the 3’-end of the gene (1.5 kb downstream of the 
rocG promoter). The binding site activates the rocG transcription even if relocated 15 kb 
downstream or upstream of the rocG promoter. The same RocR binding regions is 
essential for the regulation of downstream rocABC operon; thus, the same binding area 
works as a canonical, upstream activation sequence of rocABC and novel, downstream 
activation sequence of rocG [76]. 
 In Klebsiella pneumonia, two divergent genes, nifF and nifLA, are activated by 
transcription factors NIFA and NTRC, respectively. Binding sites for these transcription 
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factors are located upstream of transcription start sites: NIFA regulates nifF at -263 
(which is +60 relative to nifLA start), while NTRC regulates nifLA at -182 and -194 
(which is around -10 relative to nifF start). While NTRC does not influence nifF, NIFA is 
shown to activate nifLA through the same site it activates nifF. There is no evidence that 
both promoters cannot be activated at the same time [77]. 
In some cases, the location of the binding site is not important in terms of distance 
from the promoter, but in terms of its relative spatial location on the DNA helix. 
 In Pseudomonas putida, XylR auto-activates through three binding sites located 
133-173 base pairs upstream from the transcription start site. A long deletion between the 
promoter and the regulatory sequence abolish activation. The induction level does not 
change in response to short insertions and deletions as long as the fragment length is a 
multiple of one turn of the DNA helix (~11 nucleotides). Long insertions and the 
inversion of the binding site are tolerated [78]. 
Finally, some examples of non-canonical regulation were demonstrated in M. 
tuberculosis. 
 An operon espACD-Rv3613c-Rv3612c with transcription start site at -67 is 
activated by EspR at the promoter. Maximal transcription is achieved when EspR binds 
to espA activating region (EAR) located at [-1004; -884]. Moreover, deletion bringing the 
EAR region as close as ~200 nucleotides to the promoter abolishes its function [79]. 
A common theme that emerges from such reports is that binding sites located 
more distant from the promoter appear to have weaker regulatory effects. This finding 
may partially explain why regulation from more distal binding sites has not been more 
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frequently reported. Binding with weaker regulatory effects would be more difficult to 
detect with through standard perturbation experiments, and their effects could also be 
masked by stronger effects from more proximally located promoters. Although such 
distant TF binding sites may thus be less functionally impactful, the examples above 
suggest that they may remain functionally relevant nonetheless. 
Finally, it is possible that TF binding sites in prokaryotes may also play roles in 
beyond the classical activation or repression of transcriptional regulation. In particular, in 
eukaryotes, TF binding has been shown to modulate higher order DNA packaging and 
accessibility through the modulation of chromatin structure [80]. Although bacteria lack 
histone proteins associated with eukaryotic chromatin, a wide range of proteins that 
perform analogous tasks have been described in prokaryotes [81-84]. These proteins, 
termed nucleoid-associated proteins (NAPs), alter the degree of compaction, looping, and 
DNA supercoiling of bacterial chromosomes through interactions that bend, wrap, or 
bridge DNA. Through such interactions, NAPs can repress or activate the transcription of 
a substantial number of genes. Importantly, as more NAPs have been characterized, the 
distinction between proteins that modulate DNA structure and proteins that regulate 
transcription has become blurred. 
2.4. Distribution of binding sites by location 
Based on the location of region modes, ChIP-Seq binding sites can be intergenic 
or genic. Depending on the loci configuration, an intergenic site is direct, divergent, or 
convergent. Considering both E. coli and MTB genomes are approximately 90% genic, I 
find that intergenic areas are enriched for binding sites as expected from canonical model 
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of transcriptional regulation described above. However, the majority of binding events 
occur outside of upstream intergenic regions (Figure 8). To explore the potential 
transcriptional function of these binding sites, I integrate binding and expression data. 
 
Figure 8. Distribution of ChIP-Seq binding site locations. A. E. coli data. B. MTB data. 
2.5. Integration of binding and expression data 
In order to confirm that meaningful integration of binding and expression data is 
possible, I show that ChIP-Seq derived target genes of well-studied MTB TFs, KstR and 
DosR, undergo significant change in their expression in corresponding perturbation 
experiments (Figure 9). For this analysis, I assign target genes to binding sites based on 
the proximity. For an intergenic site, targets are immediate upstream and downstream 
genes. For a genic site, targets are the overlapping coding region as well as immediate 
upstream and downstream genes. 
I use a few perturbation datasets. For KstR, I compare expression fold change 
values from overexpression microarray from the Sherman Lab (unpublished data), 
knockout microarray from Nesbitt et al. [65], knockout RNA-Seq from the Galagan Lab, 
and knockout microarray from Kendall et al. [64]. For DosR, I compare expression fold 
change values from overexpression microarray from the Sherman Lab (unpublished data) 
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and overexpression RT-PCR from the Dolganov Lab (unpublished data). The absolute 
value of expression fold change is considered significant if it is not less than two. 
I apply Fisher’s exact test to calculate the probability of getting the observed 
number of ChIP-Seq derived gene targets with significant expression fold change 
compared to the total number of genes mapped to ChIP-Seq regions and the total number 
of genes that show significant expression fold change in the whole genome. KstR and 
DosR ChIP-Seq binding sites are assigned to target genes that show higher expression 
fold change than expected for the overall genome from KstR and DosR perturbation 
experiments. 
Importantly, this analysis demonstrates that weak binding sites have a distinct 
transcriptional role. 
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Figure 9. KstR and DosR regulons: binding and expression data. Light blue bars show binding site normalized 
coverage. Dark blue bars show the highest absolute value of expression fold change for binding site target gene. 
Reported p-values are the result of Fisher’s exact tests described in the text. 
Our collaborators at the Sherman Lab generated a complementary overexpression 
dataset using custom-made Nimblegen microarrays. I collapse background subtracted 
intensities from probes covering each ORF and normalize the data using RMA on all 
arrays [86,87]. If replicates are available, I average the RMA values. The fold changes 
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are derived from the comparison of overexpression experiments to the wild-type 
microarrays. 
Using this data I developed a procedure for determining the possible regulatory 
roles of identified binding sites (Figure 10, panel A). It contains the following steps: 
 Assigning target genes to transcription factor using ChIP-Seq data. If a gene 
overlaps a window of fixed size centered at a transcription factor binding site, it is a 
potential transcription factor target. I test 500, 1000, 2000, 3000, and 4000 nucleotide 
windows around the binding site to map its targets. 
 Building background expression distribution for each gene in MTB genome using 
overexpression microarrays. For a particular gene, the distribution includes expression 
values from those microarray experiments where gene regulators – found in the previous 
step – were not significantly perturbed, directly (by overexpression) or indirectly (as a 
cascade effect). 
 Calculating the empirical p-value of a transcription factor regulating a gene 
through a binding site. For each binding site to target gene pair, I score the target gene 
expression value against the gene background distribution found in the previous step. 
To address the multiple testing problem, I use the empirical false discovery rate to 
estimate the number of false positives [88,89]. For each transcription factor, I generate 
the same number of binding sites as observed in the ChIP-Seq experiment by uniformly 
testing unbound areas of the genome. Then, I apply the binding site validation method to 
the randomly generated set of binding sites. Additionally, I evaluate our findings by 
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calculating the standard positive false discovery rate [90,91] for all site-to-target p-
values. 
This method identifies a regulatory effect for 92% and 80% of previously 
identified DosR and KstR sites, respectively. The fact that some of the previously 
identified sites remain invalidated indicates that our estimates are a lower boundary of the 
capacity of this method. As we are using overexpression microarrays, we are better at 
validating activators than inhibitors: If an inhibitor is already activated in the wild-type 
strain, overexpressing it will most probably not change the expression profile. 
This method associates regulation with 43% and 36% of new DosR and KstR 
binding sites revealed using ChIP-Seq (false discovery rate = 0.25). Many, but not all, 
newly identified sites show weaker ChIP-Seq enrichment, indicating evidence for 
regulatory effects of weak binding even for well-studied regulators. 
Applying this method to all MTB regions, I can assign a potential regulatory role 
to 25% of peaks within 1,000 base pairs on either side of the site (FDR = 0.25). 
Importantly, 18% of sites are significant with q-value = 0 (Figure 10, panel B). Stronger 
binding sites are more often associated with regulation than weaker sites, independent of 
window size, suggesting a possible correlation between binding strength and regulatory 
impact. Such a correlation could explain why the stronger sites have been reported, as 
they would be more easily detected. The percentage of binding sites validated per TF 
varies a lot (Figure 10, panel C). 
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Figure 10. Integration of binding and expression data. A. The expression of a target gene when the TF is induced 
is assigned a two-tailed p-value based on a background distribution determined from control experiments and 
the induction of TFs not associated with the target gene. If any gene close to be binding site has a q-value <= 0.25 
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after multiple testing, the peak is classified as having a potential regulatory role. B. The percentage of binding 
sites that have at least one target gene validated at the FDR <= 25% are shown in blue. The estimated levels of 
validation we expect at random for the same significance level are shown in gray. Sites equal or greater than the 
coverage threshold are included in each bin. C. The percentage of binding sites validated per TF. Rv1956 has no 
sites validated, which is consistent with its function as an antitoxin [92]. 
The distance between binding sites and associated target genes is consistent with 
expectation: 40% of binding sites are located within 500 nucleotides of the start codon of 
the predicted regulated gene (Figure 11). By contrast, 76% of sites fall into annotated 
coding regions and a significant proportion are associated with regulation. 
 
Figure 11. Position of a binding site relative to its target gene suggested by expression data. The number of 
peaks assigned regulation as a function of the distance to the start codon of the predicted target gene; colored by 
genomic location relative to the target gene and genic or intergenic. 
In some cases, the above-described data integration produces surprising examples 
of transcriptional regulation that we plan to test experimentally. Figure 12 shows two 
examples where a binding site is regulating a distal target rather than the obvious 
proximal one. In the first case, expression data indicates that both binding sites are 
inhibiting Rv1556 rather than Rv1557. I hypothesize that these two binding sites are 
necessary to form a DNA loop to close off the Rv1556 promoter from RNA polymerase. 
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In the second case, a presence of small RNA (predicted by Dr. Matthew Peterson at the 
Galagan Lab) explains the binding site role. PhoP activates (according to our prediction) 
the small RNA while it acts as an inhibitor towards Rv2395. 
Using the Many Microbe Microarrays Database (M3D, [93]), I apply the same 
method to E. coli data and locate a few examples of potential looping (Figure 12, panel 
B). The M3D does not contain overexpression microarrays. To match binding and 
expression data, for each TF in our dataset, I choose a M3D condition were the TF is 
expressed the most. Considering the doubling time and safety protocols, any 
experimental validation is much easier in E. coli. 
 
 
Figure 12. The proximal promoter is not always the binding site target: Evidence for looping and small RNA 
regulation. A. MTB binding site despite being located in the promoter area of a potential target is not regulating 
the downstream target but rather the upstream gene according to the expression evidence. B. E. coli binding 
A. 
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sites show configuration characteristic of looping, expression confirms the hypothesis. Green bars indicate the 
cut sites for proposed restriction enzymes (BfuCl and HindIII). 
2.6. Conclusion 
In this chapter, I discuss the problem of gene target assignment to ChIP-Seq 
binding sites. Despite the accepted canonical model of transcriptional regulation, our 
ChIP-Seq contains many binding sites within coding regions or even within convergent 
intergenic areas. Expression and binding data integration finds the evidence that a 
significant number of genic binding sites have a distinct transcriptional function. This 
analysis also confirms the high quality of our dataset as even low coverage binding sites 
are assigned regulatory role. The unbiased analysis of the data detected examples of 
unusual site-to-target configurations. Most notably, I find examples indicative of DNA 
looping. 
Hi-C or ChIA-PET experiments [94,95], methods to study the three-dimensional 
organization of DNA, combined with our ChIP-Seq knowledge would allow us to detect 
DNA looping on a high-throughput basis. Unfortunately, most Hi-C experiments carried 
out so far were targeting interactions of sites more than 10 kB apart while current 
literature suggests that a lot of DNA-looping in prokaryotes happens within 5 kB. 
Another problem of these methods is the choice of restriction enzymes. If the purpose of 
the experiment is to look for small DNA loops, then, the restriction enzyme cut frequency 
should be high. That often causes DNA degradation. The restriction enzyme with low cut 
frequency often produces fragments too large for high resolution analysis. 
  
31 
Chapter 3. Determinants of transcription factor binding. 
3.1. Introduction 
Transcription factor binding motif is often considered the only determinant of 
binding site distribution in prokaryotes. Our efforts to profile TB and E. coli produced 
many more binding sites than expected. Considering we artificially induce our TF, one 
might argue we are observing random binding or the TF is driven to bind to every single 
location in the genome remotely resembling its binding motif. In this chapter, I predict 
and analyze TF binding motifs and compare our experimental dataset with a 
computational prediction. 
3.2. Sequence as determinant of binding 
A lot of evidence supports the idea that transcription factor binding sites share a 
common DNA sequence [96]; however, binding events are commonly found in a way 
that is biased towards more conservative motif. For example, in case of transcription 
factor perturbation experiments, the binding motif is computationally found in the 
upstream areas of target genes [97-100]. Perturbation primary (directly regulated targets) 
and secondary effects (result of the regulatory cascade) are hard to distinguish, and it is 
logical to search for a strong motif for some of the potential target genes, rather than 
explore all possible weak binding sites that are predicted with a high false discovery rate 
[101]. 
Similarly, knowledge of orthologous genes helps defining the most similar, and 
thus conserved, binding sites among groups of organisms [97]. However, evolutionary 
conserved binding sites do not comprehensively describe the binding landscape of a 
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transcription factor for a single organism [102]. This implies that by looking at only 
highly conservative binding events, we are not exploring all binding capabilities of a 
transcription factor. 
Degenerate transcription factor binding motif could arise for a few reasons [103]. 
On the one hand, weak binding sites have important biological functions. A weak binding 
site could amplify an effect of a strong binding site when the transcription factor 
concentration grows beyond a certain threshold [104, 105]. Also, a few binding sites 
could act as a strong binding site due to cooperative effects [106]. 
On the other hand, the site sequence could be only one of many factors defining 
the transcription factor binding location. DNA conformation and accessibility restrict the 
ability of the transcription factor to bind a sequence [107]. Also, the relative spatial 
location of the binding site and the target promoter could restrict the ability of a bound 
transcription factor to execute its function [108]. 
Computational motif prediction is often used to locate binding site instances 
[109,110]. Many software packages have been developed for motif discovery based on 
enriched regions identified by peak callers. Several packages in common use predate the 
development of ChIP-Seq and are general motif discovery tools. These include MEME 
[111] and AlignACE and many others [112]. More recently, tools have also been 
developed that are tailored to motif discovery from ChIP-Seq data. These include 
MEME-ChIP [113], GimmeMotifs [114], RSAT peak-motifs [115], and diChIPMunk 
[116]. 
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Motif presence alone is not sufficient to characterize a TF binding profile under 
physiological conditions [117-123]. Moreover, an experimentally demonstrated in vitro 
binding does not necessarily translate into in vivo binding event [124,125]. Various 
reports show that only a fraction of potential TF sites are bound under any given 
physiological condition which can be explained by variations in site accessibility [126]. 
This chapter explores the importance of binding sequence underlying ChIP-Seq regions. 
3.3. Binding is correlated with bound sequence 
To explore determinants of the binding identified by ChIP-Seq, I study the 
sequences underlying each of the regions. For 43 of 58 TFs that have more than 20 ChIP-
Seq binding regions (sufficient to make a good motif prediction), I can determine a good 
consensus motif. An instance of this motif can be identified underlying the vast majority 
of binding sites. De novo motifs are predicted using top 40 ChIP-Seq regions and MEME 
suite; then, all instances of predicted motifs are located and scored using FIMO and the 
motifs I predict in the previous step [127]. 
Most detected motifs are AT-rich (Figure 12) while MTB genome is 
approximately 65% GC-rich. AT-rich sequences are known to be more flexible [128], 
and TFs tend to bind AT-rich motifs [129]. 
  
34 
 
Figure 12. AT-content of de novo predicted MTB motifs. 
As a general trend, variations in motif instances can be associated with 
differences in apparent binding affinity approximated by ChIP-Seq coverage. 
An example for KstR is shown in Figure 14. 
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Figure 14: Binding site affinity corresponds to sequence and occupancy at different levels of expression. For 
transcription factor KstR, the heatmap shows experimentally detected binding sites at the bottom (Bound Sites); 
and binding sites found by sequence similarity but not experimentally at the top (Unbound Strong Motifs). Each 
row is a binding site, and each column is a particular position of the binding motif. The KstR binding motif 
describing all sites in the heatmap is shown at the bottom of the figure (Full Motif). Binding site coverage is 
shown in 4 bar plots, corresponding to 4 induction levels as indicated by inducer (ATC) concentration. As shown 
by arrows, high coverage binding sites correspond to a wide high-affinity motif, while low coverage sites 
correspond to a degraded version of the same motif. 
In the bottom portion of the Figure 14, each row represents the sequence region 
for a single binding site with the nucleotides color coded. The rows are ordered from the 
binding peaks with the most enrichment at the top down to binding peaks with the lowest 
enrichment at the bottom. A clear consensus motif can be detected as shown, which 
corresponds to the published binding motif for KstR and the core of this motif is visible in 
the heat map across all the binding sites. Individual binding sites, however, display 
differences in their underlying motifs. Underlying the strongest binding sites are 
sequences that contain not only the core palindrome, but also conserved accessory bases 
known to play an important role in shaping affinity [130]. Less enriched peaks, by 
contrast, are often found to lack these accessory bases. Furthermore, in some cases only 
one half of the palindrome is present. Binding to such half sites was described in the 
earliest ChIP-Seq experiments in eukaryotes [132]. This pattern suggests that, to a first 
approximation, differences in enrichment at different binding sites can often be explained 
by differences in the affinities of the underlying sequence motif.  
Correlation between motif score and ChIP-Seq coverage for all MTB TFs with 
sufficient number of regions is shown in Figure 15. 
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Figure 15. Correlation between ChIP-Seq height and predicted motif score. For every ChIP-Seq experiment, I 
sort regions by height and predict the de novo motif in a sliding window of 20 regions using MEME. Green line 
shows the de novo motif score (secondary Y-axis – negative log10 e-value of the motif). Blue bars show enriched 
regions (primary Y-axis – log2 normalized region height). Correlation coefficient is in the title of each plot. 
3.4. Expression level of the TF of interest impacts its binding profile 
The difference in affinities of different binding sites is also reflected in 
experiments in which ChIP-Seq is performed on TFs induced to different levels. ChIP 
enrichment is a function of the number of cells in which a site is bound [132,133] which 
is governed by the affinity of the site and the concentration of the factor. By over-
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expressing a factor, we expect to increase the occupancy of strong sites up to a saturation 
limit while also occupying, and thus detecting, weaker affinity sites. In the example 
shown in Figure 14, when KstR is lowly expressed, only a small number of low peaks are 
identified and a number of gold standard sites are missed. As expression increases, 
overall peak heights increase, while maintaining roughly the same relative heights, and 
additional lower peaks are revealed. At the highest levels of expression, the increase in 
enrichment of strong sites begins to level off.  
Remarkably, we observe the same flexibility of binding profile in a single-cell 
eukaryotic organism, Neurospora crassa. SUB-1 is a light-response TF and its levels 
within the cell oscillate [134,135]. We carry out ChIP-Seq on SUB-1 using a native 
promoter at different time points of the light-response. As a result we observe the binding 
profile expand and diminish together with the TF levels (Figure 16). 
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Figure 16. Degradation of the SUB-1 motif. Peak heights for each experiment are shown in the bar plots on the 
right, while the nucleotide composition around each binding site is shown in the heat map. 
3.5. Experimental regions and computational motifs 
Importantly, the binding sites detected do not simply reflect the association of 
induced TFs with all available motifs. For the majority of factors mapped, only a fraction 
of computational identified instances of motifs in the genome are typically bound based 
on ChIP-Seq (Figure 17). In the example for KstR in Figure 14, numerous instances of 
the strongest KstR motif can be detected throughout the genome that are not bound in any 
of the ChIP-Seq experiments we have performed. These instances include examples of 
the identical sequence in multiple genomic locations, one of which is bound while the 
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other is not (Figure 18). Binding of the majority of TFs thus displays genome context 
specificity: only a fraction of the possible binding sites appear occupied and this 
differential occupancy is highly reproducible. This phenomenon is well-known in 
eukaryotic systems, but is less well appreciated in bacteria. Examples are known of TFs 
in prokaryotes that appear to be able to bind to any available motif instance regardless of 
genomic location [136]. However, the data from MTB, as well as corresponding data 
from ChIP-Seq in E. coli, indicates that for many bacterial TFs, parameters other than the 
underlying sequence determine whether individual motif instances are bound in vivo. The 
determinants of this specificity are not fully understood and experimental validation is 
needed. 
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Figure 17. Sensitivity of a computational motif search and de novo predicted motif scores. Panels A and B show 
the percentage of computationally predicted binding motifs bound in a ChIP-Seq experiment at a relatively 
stringent threshold (p-value <= 0.0001) for MTB and E. coli. Panel C tests 4 different p-value thresholds and 
reports percentage and number of computationally predicted binding sites bound in ChIP-Seq experiment. 
 
A. 
C. 
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Figure 18. The same binding sequence bound in one area of the genome and not bound in the other. A. Four 
KstR binding sites share exactly the same sequence: CAACGAGTTC. Two instances appear bound in ChIP-Seq 
experiment, and two other instances are not bound. B. Eight KstR binding sites share exactly the same sequence: 
AGAACGTGTTG. Five instances have no or very low enrichment while three other instances bind with various 
levels of coverage. 
B. 
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3.6. Binding sites and accessibility 
Determining the reason for selective binding of motif instances requires 
experimental validation. An EMSA experiment on such binding motifs would be the first 
step. If in vitro and in vitro experiments both show differential binding, then, the likely 
explanation is the presence of accessory binding positions not captured by the binding 
motif. If in vivo experiment shows differential binding while in vitro experiment indicates 
TF always binds the sequence, then, the likely explanation is DNA accessibility. 
Something (potentially nucleoid-associated proteins discussed before) is restricting the 
TF ability to bind DNA in some genomic locations but not the others. Our preliminary 
EMSA experiments (carried out by Dr. Paul Iazzetti) indicate that the latter is might be 
true. 
To test the accessibility hypothesis, I compare binding profiles of known E. coli 
NAPs (H-NS, Fis, and IHF) to E. coli TF binding profiles. NAP ChIP-Seq data was 
published previously [137,138]. I expect that unbound motif instances are enriched for 
NAP binding sites while bound motifs are not. Surprisingly, the opposite is true: bound 
sites of some TFs are statistically (Fisher’s exact test) enriched for NAP sites (H-NS and 
Fis in particular) while other TFs show no enrichment either way. We also know that 
MTB binding sites are enriched for Lsr2, H-NS homolog. This result could be a result of 
a ChIP-Seq artifact described in Chapter 1: perhaps, NAPs tend to cause unspecific 
enrichment in ChIP-Seq experiments. It could also be an issue of finding a more refined 
way to carry out the analysis. Finally, there is an association between NAP and TF 
binding. A lot of NAPs seem to be abundantly present during the exponential growth 
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phase: In order to grow efficiently, cells need to tightly control their DNA conformation 
and thus, transcription [139]. That implicates that NAPs and TFs might bind in close 
proximity as their functions are interconnected. A very high resolution analysis might be 
able to support this hypothesis [140]. 
3.7. Conclusion 
ChIP-Seq offers experimental binding data which is not dependent on prior 
assumption about binding site sequence. This chapter explores sequences underlying 
ChIP-Seq regions. I find that in a lot of cases ChIP-Seq regions contain some common 
binding pattern; however, the motif is often degenerate. Moreover, for some TFs, the 
ChIP-Seq coverage correlates well with the motif score. A whole-genome computational 
search for binding sites produces some conservative – in terms of sequence – instances 
that are not bound according to the experiment. 
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Chapter 4. Evolution of regulation in Actinomycetes: Benefits of ChIP-Seq for 
evolutionary studies. 
4.1. Introduction 
Bacterial regulons evolve through changes in regulatory proteins, their binding 
sites, and their target genes; a study of these complex interconnected processes heavily 
depends on computational methods and is limited by the absence of experimental binding 
data in related organisms. Our dataset allows integrating binding data with expression to 
answer questions about evolution of transcriptional regulation in Actinomycetes. 
Importantly, this approach steps away from the parsimonious assumption that if the 
regulator, its binding motif, and the target gene are conserved than the interaction is also 
conserved among related organisms. 
This chapter pursues two different questions: (1) How does experimental 
knowledge compare to computational predictions of binding in the context of multiple 
organisms? (2) To what extent are ChIP-Seq binding sites and target genes conserved? 
4.2. Evolution of M. tuberculosis 
Specialized pathogens (such as M. tuberculosis or M. bovis) comprise a minority 
of Mycobacterium genus. The rest of the genus contains environmental opportunistic 
bacteria called non-tuberculous mycobacteria (NTM). The major structural feature that 
these organisms share is a hydrophobic, lipid-rich outer membrane containing unique 
mycolic acids [141]. Some NTM are often used as model organisms to study MTB 
infection, for example, M. smegmatis (MSMEG), a soil dwelling, and rapid growing 
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saprophyte [142]. The need for model organisms is dictated by the fact that M. 
tuberculosis is a category three human pathogen with long doubling time (22 hours). 
It is not completely clear how M. tuberculosis developed from environmental 
bacteria. It is suggested to be a result of a biphasic evolutionary process. First, the 
genome gained pathogenic features via horizontal gene transfers (HGT), duplications, 
and deletions; and then, the system was conserved with some unnecessary genes being 
deleted [143]. About 64% of MTB genes and 75% of MTB transcription factors have an 
ortholog in the genome of M. smegmatis [144]; however, M. smegmatis has about 1.7 
times more genes than M. tuberculosis. Despite the relatively high level of conservation, 
an alignment of these two genomes demonstrates many genome re-arrangement events 
(Figure 19). 
 
Figure 19. Synteny map between MTB and MSMEG. 
Comparative studies of opportunistic and specialized pathogens in 
Mycobacterium genus revealed that some key transcription factors for MTB infection are 
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evolutionary conserved in NTM genomes. For example, the kstR inhibitor controls a large 
regulon for lipid uptake and catabolism in M. tuberculosis and M. smegmatis. It was 
experimentally shown, that both the protein and its binding site motif are highly 
conserved between these two organisms [145]. Although related species often use 
orthologous regulatory proteins to react to similar stimulus, the conservation level of the 
target regulon varies [146]. 
4.3. Regulon evolution studies 
The evolution of a regulon can be described through gain, loss, and change (of the 
sequence and/or order) of transcription factor, its target genes and binding sites [147]. In 
eukaryotes, genome composition does not change a lot, and existing evolutionary studies 
focus on the binding site turn-over through point mutations as the driving force of 
evolution [148]. Using that simplification, a model of evolution was built and 
evolutionary rates calculated for a regulon under complex combinatorial control [149]. 
In prokaryotes, the genome composition is highly dynamic [150], thus, 
complicating any attempts to model the regulon evolution. Moreover even when 
orthologous transcription factors in related organisms do not change a lot, a single 
mutation in the regulatory protein can lead to changes in the binding site motif. Some 
studies focus on the comparison of targets of orthologous transcription factors to define 
the conserved core and evolutionary variable parts of the regulon across distant 
organisms [151]. However, a complete model describing the regulon evolution should 
expand to include biological causes of target gene and binding site gain and loss. For 
target genes, those processes include (1) gene duplication; (2) horizontal gene transfer by 
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phages, plasmids and pathogenicity islands; (3) recombination and rearrangement; (4) 
gene loss; (5) accumulation of pseudogenes and insertion elements. Biological causes for 
evolution of binding sites are even more complex, because they include both the 
processes typical for target genes and point mutations characteristic of intergenic 
sequences [152]. 
4.4. Conservation of MTB binding sites and transcription factors 
As discussed in Chapter 3, computational prediction of TF binding sites produces 
many false positives. One way to reduce false positives, mentioned previously, is to 
constrain the motif search to proximal promoter areas as they are the most likely to 
contain true binding sites. Another way is to use the information from multiple related 
organisms and analyze the alignment of orthologous genome areas. A true binding site 
would be under positive selection and conserved better than a false positive that would 
be, ideally, undergoing neutral evolution [152]. Again, this method works for intergenic 
areas only as coding areas are under strong positive selection to maintain protein 
composition [153]. Very few studies attempt locating binding sites within coding regions 
– hypothetically, such areas are undergoing even stronger positive selection – using 
synonymous positions to estimate neutral evolution [154]. 
To test this assumption for Actinomycetes, I compared motif prediction results to 
our MTB ChIP-Seq dataset at various thresholds of the motif score and conservation. The 
motif score is the negative p-value calculated by FIMO and the motif conservation is the 
adjusted entropy of the multiple sequence alignment. Multiple sequence alignments used 
in this analysis contain 31, 19, and 8 genomes of MTB relatives (Figure 20) and were 
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previously published by McGuire et al. [144]. The percentage of computational motifs 
that appeared to be bound experimentally (the precision, i.e. true positive over true and 
false positive motifs) and the percentage of true binding regions recovered through a 
motif search (the sensitivity, i.e. true positive over false negative and true positive 
regions) at various levels of motif score and conservation are shown in Figure 21. 
Remarkably, motif conservation is not predictive of a true binding in Actinomycetes. 
That holds true for genic and intergenic binding sites and all 3 multiple alignments tested. 
 
Figure 20. Phylogenetic tree of Actinomycetes [4]. 
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Figure 21. Motif score and conservation as predictors of ChIP-Seq binding. 
I also looked for correlation between the following TF parameters: regulon size, 
TF motif score, TF sequence conservation (as defined in [155]), TF age, regulon 
sequence conservation (as defined in [154], mean across all gene targets), regulon age, 
and TF regulatory impact. Both gene sequence conservation and gene age were 
calculated using 31-organism multiple alignment [144]. Gene age was defined in two 
ways: (1) the evolutionary time between the last common Actinomycetes ancestor having 
a corresponding ortholog and MTB; and (2) the total evolutionary time across all 
branches of a corresponding ortholog tree. 
None of these parameters are correlated. This contradicts previously suggested 
positive correlation between regulon size and TF age [156] and the possibility that 
repressors are more conserved than activators [147]. 
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4.5. Conservation of ChIP-Seq binding between MTB and MSMEG. 
We successfully performed ChIP-Seq experiments for 5 conserved transcription 
factors across two to four Mycobacteria relatives (data is described in Table 1, M. 
tuberculosis, M. avium, M. smegmatis, and Rhodococcus sp.). De novo predicted motifs 
of orthologous genes are very similar with exception of Rv0081 (Figure 22). Rv0081 is 
also the only orthogroup with low levels of sequence conservation (Table 1) while 4 other 
orthogroups are conserved significantly above average. 
Table 1. Orthologous TFs ChIPed in MTB and its relatives. Columns are: the name of the orthogroup, the name 
of the TF ChIPed, number of binding regions after all filtering steps, the normalized coverage of the highest 
region, average region width, motif score (negative log10 e-value), motif AT-content, protein and nucleotide 
conservation of TF. 
Orthogrou
p 
TF name ChIP-Seq regions Motif Conservation 
total 
# 
max 
height 
average 
width 
score AT-content protein nucleotide, 
% 
dosR Rv3133c 203 1339 420 19 47.5 0.84 77 
MSMEG_5244 139 187 444 24 45.8 
kstR Rv3574 315 196 323 82 57.7 0.69 83 
MAV_0584 43 1442 600 136 57.7 
MSMEG_6042 157 518 375 187 59.3 
RHA1_ro04482 685 197 271 115 60.2 
lsr2 Rv3597c 162 109 801 49 68.2 0.58 81 
MSMEG_6092 410 197 917 29 68.9 
Rv0081 Rv0081 519 263 354 21 62.7 0.26 55 
MSMEG_6451 527 1756 336 28 54.4 
Rv3249c Rv3249c 301 1353 362 67 57.1 0.68 75 
MSMEG_1842 371 3680 225 26 45.7 
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Figure 22. Predicted binding motifs for 5 conserved TF orthogroups ChIPed in MTB and relatives. 
Using this dataset, I analyze binding site conservation between MTB and 
MSMEG. 
• I compare sequence conservation between ChIP-Seq sites to randomized 
predicted motifs for corresponding TFs. Potentially conserved MTB sites are mapped to 
some area of MSMEG genome with any identity score. Conserved MTB sites are aligned 
to MSMEG with at least 90% identity. Approximately 60% genic and 45% intergenic 
sites have potentially conserved sequences; of those, approximately 40% genic and 15% 
intergenic sites are actually conserved. As expected, sequences of genic sites are better 
conserved than those of intergenic sites (similar results reported in [157]). Consistent 
with Figure 21, sequences underlying ChIP-Seq regions are not conserved better than 
randomized motifs (Figure 23, panels A1 and A2). Moreover, sequences underlying genic 
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ChIP-Seq regions are conserved slightly less than randomized motifs. That confirms a 
previously published idea that spurious binding motifs are undergoing negative selection 
[158,159]. 
As the sequence conservation is not a reliable way to map ChIP-Seq binding sites, 
I used target genes and the loci configuration as anchors. 
• Less stringent definition of conserved sites uses target genes only: If a binding 
site has a target conserved in both TB and MSMEG, it is potentially conserved (Figure 
23, panel B1). If a binding site has the same orthologous target in both TB and MSMEG, 
it is actually conserved (Figure 23, panels B2). Approximately 55% genic and 55% 
intergenic sites are potentially conserved; of them, approximately 23% genic and 32% 
intergenic site are actually conserved. 
• More stringent definition of conserved sites uses target genes and loci 
configurations: If a binding site has a target conserved in both TB and MSMEG and it 
can be mapped between two organisms, it is potentially conserved (Figure 23, panel C1). 
If a binding site has the same orthologous target in both TB and MSMEG and it is located 
in the same relative location, it is actually conserved (Figure 23, panels C2). 
Approximately 55% genic and 43% intergenic sites are potentially conserved; of them, 
approximately 6% genic and 15% intergenic site are actually conserved. 
Intergenic sites are conserved better than genic sites, which corroborates the 
importance of intergenic sites. With either definition, ChIP-Seq sites, both intergenic and 
genic, are conserved significantly better than randomized motifs. That adds to the 
evidence from Chapter 2 that genic sites are not merely artifacts. 
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Figure 23. Conservation of MTB binding sites in MSMEG genome. We use three definitions of conservation: (A) 
sequence conservation, (B) conservation of the target, and (C) loci and target conservation combined. We 
calculate two types of statistics for each definition of conservation: (1) percentage of all MTB binding sites that is 
potentially conserved and (2) percentage of potentially conserved binding sites that is truly conserved. Each 
statistics is calculated for genic and intergenic sites separately. Three different site coverage thresholds are 
tested (0, 10, and 40). Grey bars indicate expected values from randomized computationally predicted motifs. 
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We have kstR ChIP-Seq data for 4 organisms: M. tuberculosis, M. avium, M. 
smegmatis, and Rhodococcus sp. As expected, many highly conserved binding sites are 
located in promoter areas of their target genes and enriched for both strong binding 
motifs and high expression impact (Figure 24, Example A). Some genic binding sites are 
conserved across all 4 organisms as well (Figure 24, Example B). However, I locate 
potential examples of DNA looping (Chapter 2 and Figure 24, Example C) and DNA 
accessibility (Chapter 3 and Figure 24 example D) that are good candidates for 
experimental validation.  
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Figure 24. Examples of kstR binding site conservation across 4 Mycobacteria relatives. In each example, first 4 
panels contain ChIP-Seq data and next 4 panels contain genome annotations for M. tuberculosis, M. avium, M. 
smegmatis, and Rhodococcus sp. respectively. 
4.6. Conservation of target genes across Actinomycetes 
Despite high conservation of TFs and motif similarity, target genes within regulon 
are conserved well below expected from whole genome level of conservation (Figure 25). 
Table 2 shows  
 
Figure 25. Intersection of target genes between TB (blue) and MSMEG (green) for 5 regulons and whole 
genomes based on orthology from [4]. 
Table 2. Regulon conservation between TB and MSMEG. Number of genes regulated in MTB or MSMEG but 
not in the other organism (“no conservation), number of genes regulated in MTB or MSMEG but not in the 
other organism although the gene itself is conserved (“target conserved), number of genes conserved and 
regulated in both MTB and MSMEG (“target and regulation conserved”). 
  No conservation Target conserved Target and regulation conserved 
Rv3133c 266 271 17 
Rv3574 327 331 55 
Rv3597c 570 206 22 
Rv0081 893 596 62 
Rv3249c 309 453 63 
I use the binding information for orthologous transcription factors in M. 
tuberculosis and M. smegmatis to study evolution of target genes in Actinomycetes. To do 
that, I found all Mycobacterial orthogroups containing at least one gene regulated by a 
transcription factor of interest using the following steps. (1) I combine motifs for 
orthologous transcription factors from M. tuberculosis and M. smegmatis and scan 
genomes of 19 other related Actinomycetes to find all potential binding sites (Figures 2). 
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The most distant ortholog is found in N. farciniia. I still find a number of sites in C. 
glutamicum, C. efficiens, C. diptheriae, A. cellulolytica, P. acnes, and B. longum where 
no TF ortholog was reported. (2) Based on locations of binding sites, I assign target genes 
for orthologous transcription factors in 21 organisms. For this analysis, I assume that the 
existence of the transcription factor binding site upstream or within a gene indicates that 
the gene is regulated by the transcription factor, i.e. is part of the regulon in a given 
organism. (3) I use orthology to map target genes between organisms. As our 
experimental knowledge is limited, I am interested in orthogroups containing target genes 
from M. tuberculosis and M. smegmatis. 
In figure 26, target orthogroups are grouped as: (1) always regulated by the 
transcription factor of interest (core regulon), or (2) gaining or losing regulation by the 
transcription factor of interest (variable part of the regulon). Interestingly, the kstR and 
dosR regulons show different stories. These regulons are comparable in size, and the 
transcription factors themselves are very well conserved. However, only 15 orthogroups 
are regulated by the dosR in both M. tuberculosis and M. smegmatis. The variable parts of 
the regulon seem to evolve through binding site and gene turn-over equally. 
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Figure 26. The evolution of the regulation of orthologous transcription factors. Left heatmap is M. tuberculosis 
overexpression data (log2 fold change); each row is an MTB gene. Right heatmap contains ChIP-Seq peak 
heights for M. smegmatis and M. tuberculosis; each row is M. smegmatis (first column) or M. tuberculosis (second 
column) gene. Center heatmap contains regulation data; rows are orthogroups and columns are organisms, each 
cell corresponds to a gene. Orange and red indicate weaker and stronger regulation of the gene (estimated using 
motif p-values). Light blue means the genome (column) contains a gene belonging to the orthogroup (row); 
however the gene is not regulated by the transcription factor. Dark blue means that the genome does not contain 
a gene belonging to the orthogroup. 
4.7. Conclusion 
In this chapter, I combine the single-genome data (binding site occupancy, motif 
strength, and target gene expression) with the data gleaned from multiple related 
genomes (sequence conservation, binding conservation, and the organism history) to 
study regulon evolution. Comparative data supports the conclusions made in previous 
chapters: Low coverage and genic binding sites are not merely artifacts of our protocol 
and some of them have transcriptional function; the binding sequence is not the only 
determinant of binding. I also find that regulon composition is less conserved than 
expected, both binding site and gene turn-over contribute to regulon evolution. 
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APPENDIX 
Table 3. ChIPed TFs from MTB, M. avium, M. smegmatis, and Rhodoccocus sp. RHA1. Table columns contain: 
TF name, ChIP information (number of enriched regions (after all filters are applied), normalized height of the 
best region, average width of regions, standard deviation of region widths, mean coverage in ChIP experiment), 
motif information (negative log10 e-value of de novo predicted motif and AT-content), Actinomycetes 
evolutionary conservation information (conservation of protein sequence, two measurements of protein age). 
TF ChIP-Seq Motif Evolutionary conservation 
# regions max 
height 
average 
width 
stddev 
width 
mean 
coverage 
-LOG10 e-
value 
AT-
content, % 
protein 
conservation 
protein age 
(1) 
protein age 
(2) 
MAV_0584 43 1442 600 871 355 136.2 57.7 0.688 1.33 0.24672 
MSMEG_0051 8 515 1236 1809 97 -3.6 48.9 0.783 0.67 0.1603 
MSMEG_1415 3 115 3023 2643 169 -2.3 63.3 0.754 1.63 0.34529 
MSMEG_1842 371 3680 225 62 3 25.7 45.7 0.677 1.32 0.24672 
MSMEG_1914 212 108 861 843 252 10.7 60.8 0.613 2.27 0.29226 
MSMEG_3659 3 7 468 106 218 -2.1 54.1 0.617 1.23 0.24672 
MSMEG_5034 4 13 494 54 174 -2.3 60.6 0.686 0.66 0.24672 
MSMEG_5244 139 187 444 438 135 24.1 45.8 0.836 1.16 0.24672 
MSMEG_5872 14 37 312 49 171 26.5 53.5 0.795 2.59 0.34529 
MSMEG_6042 157 518 375 239 242 186.8 59.3 0.688 1.33 0.24672 
MSMEG_6092 410 197 917 1181 178 29.2 68.9 0.575 2.61 0.38996 
MSMEG_6451 527 1756 336 93 215 28.2 54.4 0.257 1.33 0.24672 
RHA1_ro04482 685 197 271 97 106 115.5 60.2 0.688 1.33 0.24672 
Rv0022c 6 74 290 129 442 -1.9 59.5 0.917 0.3 0.11688 
Rv0023 287 119 649 391 331 14.0 59.8 0.901 0.31 0.11688 
Rv0042c 2 43 781 227 89 11.0 65.9 0.299 3.18 0.38996 
Rv0043c 48 25 2023 1614 252 5.6 52.2 0.47 1.28 0.34529 
Rv0047c 481 558 318 198 272 39.7 58.8 0.642 2.2 0.34529 
Rv0054 3 15 1209 303 105 -3.7 41.7 0.572 2.4 0.29226 
Rv0067c 5 591 544 182 313 19.7 63.2 0.679 0.99 0.18199 
Rv0081 519 263 354 206 303 21.1 62.7 0.257 1.33 0.24672 
Rv0135c 331 1538 313 162 359 41.4 37.8 0.8 0.76 0.1603 
Rv0195 20 58 487 116 107 -0.6 67 0.667 1.33 0.24672 
Rv0232 2 38 754 160 251 12.9 68 0.634 1.66 0.34529 
Rv0238 3 177 405 48 414 7.6 71.1 0.699 1.9 0.34529 
Rv0273c 51 3584 347 140 426 24.9 44 0.543 1.76 0.34529 
Rv0275c 16 93 391 146 239 17.9 53.8 0.543 1.76 0.34529 
Rv0302 213 1630 342 108 352 52.0 45.1 0.504 2.28 0.58282 
Rv0324 324 161 394 271 220 1.7 70 0.686 0.66 0.24672 
Rv0330c 4 231 989 959 238 18.0 65.8 1.001 0 0.00036 
Rv0339c 76 76 1033 1565 364 6.9 35.1 0.23 0.94 0.18199 
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Rv0348 3 312 348 106 401 -1.4 63.3 0.647 0.41 0.24672 
Rv0353 3 478 806 248 136 -1.4 46.6 0.385 3.89 0.58282 
Rv0377 1 6 225 0 60 4.5 73.7 0.588 1.41 0.34529 
Rv0445c 2 12 1967 120 352 33.9 66.6 0.23 2.36 0.58282 
Rv0465c 88 339 831 749 230 29.0 51 0.754 2.27 0.29226 
Rv0472c 6 168 492 102 135 6.0 63.6 0.332 1.9 0.34529 
Rv0474 19 18 865 502 204 13.7 57.6 0.44 2.06 0.34529 
Rv0494 66 818 337 97 232 75.6 39.7 0.654 0.78 0.34529 
Rv0576 31 111 324 218 237 24.4 50.5 0.64 0.7 0.24672 
Rv0599c 2 19 274 34 88 16.0 63.5 0.619 0.4 0.1603 
Rv0602c 70 70 598 918 166 14.3 61.8 0.705 1.32 0.34529 
Rv0608 8 435 875 1593 278 0.3 44.4 0.924 0.29 0.1603 
Rv0653c 45 3331 585 795 218 30.2 59.2 0.559 1.64 0.34529 
Rv0674 1 177 402 0 280 -1.2 73.3 0.716 1.37 0.34529 
Rv0678 164 913 289 179 306 21.9 56.6 0.573 1.57 0.34529 
Rv0681 4 12 366 100 300 9.9 62.1 0.801 0.95 0.18199 
Rv0691c 295 336 299 265 430 52.1 48.1 0.728 1.33 0.24672 
Rv0735 1 6 769 0 382 32.5 71.2 0.713 1.33 0.24672 
Rv0744c 1 5 224 0 418 13.6 81.8 0.941 0 0.00036 
Rv0757 101 748 466 437 263 50.2 51.8 0.795 2.59 0.34529 
Rv0767c 244 48 396 216 295 4.7 43.1 0.655 1.2 0.24672 
Rv0818 14 32 476 183 124 20.0 57.2 0.665 2.85 0.58282 
Rv0827c 5 299 1432 1295 278 6.5 55.9 0.522 1.51 0.29226 
Rv0880 12 88 262 118 160 6.8 67.4 0.757 2 0.34529 
Rv0891c 5 16 497 473 247 3.3 63.3 0.59 0.57 0.1603 
Rv0894 1 6 459 0 353 20.4 67.6 0.859 1.95 0.3647 
Rv0903c 1 8 825 0 345 3.9 70.8 0.867 1.47 0.24672 
Rv0967 624 230 309 104 478 22.8 14.6 0.441 1.51 0.29226 
Rv1019 1 14 331 0 330 4.2 68.3 0.596 2.52 0.38996 
Rv1033c 337 2377 314 144 275 22.8 57.1 0.685 1.7 0.34529 
Rv1049 213 64 303 201 324 14.8 33.1 1.002 0 0.00036 
Rv1152 4 282 428 278 255 5.5 53.3 0.336 1.16 0.24672 
Rv1167c 14 381 539 494 248 7.6 61.5 0.529 2.45 0.58282 
Rv1176c 2 213 483 272 248 -1.9 68.7 0.552 1.33 0.29226 
Rv1186c 3 148 714 660 228 9.1 81.6 0.74 0.95 0.24672 
Rv1189 2 6 337 45 413 35.7 67.8 0.233 1.03 0.24672 
Rv1219c 61 2441 391 288 393 59.2 45.9 0.631 1.33 0.24672 
Rv1255c 28 552 517 579 273 1.9 46 0.591 1.28 0.34529 
Rv1287 2 10 405 152 300 40.7 66.6 0.568 2.94 0.58282 
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Rv1332 1 6 604 0 277 41.4 67.7 0.591 3.09 0.34529 
Rv1353c 491 392 305 94 428 23.9 49 0.66 1.71 0.38996 
Rv1395 4 25 2113 1351 207 18.9 62.7 0.767 0.68 0.18199 
Rv1404 48 941 684 580 450 13.6 60 0.422 1.5 0.34529 
Rv1423 294 115 253 84 441 52.1 27.7 0.781 3.89 0.58282 
Rv1460 3 8 418 115 204 19.1 67.1 0.522 3.5 0.38996 
Rv1473A 261 889 379 99 462 119.6 58.7 0.259 2.47 0.38996 
Rv1556 10 166 515 368 426 8.1 39.8 0.528 1.61 0.34529 
Rv1626 1 9 325 0 292 -2.9 75 0.693 2.61 0.38996 
Rv1674c 16 247 257 70 146 20.6 61.8 0.753 0.56 0.24672 
Rv1675c 8 56 376 251 302 17.0 43.5 0.692 1.34 0.3647 
Rv1719 141 621 335 95 391 24.8 33.1 0.617 1.49 0.34529 
Rv1773c 7 74 779 337 347 -7.3 50.1 0.657 0.76 0.1603 
Rv1776c 472 204 327 150 395 7.3 39.7 0.644 0.95 0.18199 
Rv1816 404 313 282 86 471 62.4 35.7 0.617 1.23 0.24672 
Rv1828 15 1510 344 71 329 23.1 47 0.619 3.5 0.38996 
Rv1830 3 59 1205 1540 180 -1.3 67.2 0.635 3.89 0.58282 
Rv1846c 14 103 383 221 385 29.3 46.2 0.742 1.97 0.29226 
Rv1909c 6 19 1894 1767 185 7.1 57.5 0.534 1.98 0.34529 
Rv1956 24 150 374 223 229 5.1 50 0.697 0.82 0.29226 
Rv1985c 33 190 786 1139 321 13.6 65.6 0.641 2.55 0.3647 
Rv1990c 435 187 340 169 199 10.2 43.1 0.967 0.4 0.1603 
Rv1994c 84 452 280 82 307 31.0 63.6 0.595 1.09 0.24672 
Rv2009 1 7 851 0 140 2.6 70 1.003 0 0.00036 
Rv2011c 264 855 403 203 119 1.4 42.2 0.764 0.78 0.34529 
Rv2021c 201 49 508 282 313 7.3 43.1 1.003 0 0.00036 
Rv2034 269 908 263 121 152 49.2 43.2 0.469 1.18 0.24672 
Rv2069 3 66 637 234 115 9.8 74.4 0.342 0.67 0.18199 
Rv2160A 1 12 1795 0 40 -2.7 70.8 0.647 0.41 0.24672 
Rv2160c 2 1411 2900 2744 131 -1.4 40 0.647 0.41 0.24672 
Rv2250c 248 1455 326 91 272 8.9 47.8 0.597 1.68 0.34529 
Rv2324 248 35 282 118 439 11.8 48.7 0.754 1.63 0.34529 
Rv2359 10 1527 371 124 353 48.4 65.1 0.579 4.11 0.38996 
Rv2374c 3 24 416 108 320 1.6 57.5 0.533 4.5 0.58282 
Rv2506 20 507 871 993 342 40.5 53.8 0.481 1.89 0.29226 
Rv2640c 1 5 738 0 290 18.4 64.5 0.565 1.92 0.34529 
Rv2720 21 130 467 167 218 79.4 61 0.594 4.5 0.58282 
Rv2745c 1 6 348 0 163 21.4 61.8 0.285 3.45 0.58282 
Rv2779c 6 375 389 189 373 2.5 59 0.709 1.47 0.34529 
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Rv2779c 5 627 466 178 116 1.3 69.6 0.709 1.47 0.34529 
Rv2788 45 183 1329 1241 121 109.3 52.2 0.654 1.72 0.29226 
Rv2827c 13 208 488 287 105 9.0 45.5 0.938 0 0.00036 
Rv2884 52 102 485 359 179 29.3 56.3 0.774 0.31 0.11688 
Rv2887 61 2798 780 809 277 53.8 55 0.65 0.66 0.18199 
Rv2912c 6 1266 794 260 111 20.7 64.2 0.718 0.77 0.18199 
Rv2989 128 193 491 620 214 20.7 41.6 0.43 2.73 0.38996 
Rv3050c 3 76 606 322 261 16.4 60.5 0.478 1.47 0.24672 
Rv3058c 3 44 373 52 146 -1.6 70.8 0.741 0.95 0.18199 
Rv3066 17 2263 388 368 235 32.1 48.1 0.52 0.95 0.18199 
Rv3133c 203 1339 420 446 126 18.8 47.5 0.836 1.16 0.24672 
Rv3143 1 6 1114 0 311 15.1 62.4 0.624 2.47 0.38996 
Rv3160c 22 94 753 1021 296 2.9 58.3 0.948 0 0.00036 
Rv3167c 6 15 462 431 356 -1.8 48 0.76 0.76 0.1603 
Rv3173c 28 200 553 226 40 -12.1 47.7 0.662 0.62 0.24672 
Rv3183 1 24 371 0 188 27.9 66.9 0.849 0.2 0.11688 
Rv3219 17 34 408 182 222 -9.7 55 0.506 3.5 0.38996 
Rv3223c 80 74 367 169 372 -2.9 59.2 0.613 2.27 0.29226 
Rv3246c 46 402 583 477 159 58.3 55.3 0.835 3.09 0.34529 
Rv3249c 301 1353 362 142 375 67.1 57.1 0.677 1.32 0.24672 
Rv3260c 19 34 644 1090 87 -4.0 51 0.397 3.89 0.58282 
Rv3286c 30 36 753 513 98 4.1 43.9 0.801 1.18 0.24672 
Rv3291c 3 104 803 115 232 16.6 63.9 0.674 2.56 0.58282 
Rv3334 1 10 1004 0 249 24.0 73.4 0.466 1.52 0.3647 
Rv3405c 3 2192 2205 1164 234 14.9 59.6 0.775 0.66 0.18199 
Rv3414c 5 12 574 407 310 32.2 68.1 0.607 2.27 0.29226 
Rv3416 7 36 335 18 373 -0.4 54.4 0.352 3 0.58282 
Rv3488 6 220 262 58 263 3.0 44.7 0.939 0.2 0.09951 
Rv3557c 7 115 345 197 424 20.0 63.5 0.765 1.7 0.34529 
Rv3574 381 99 260 99 245 33.1 49 0.688 1.33 0.24672 
Rv3597c 162 109 801 677 394 49.3 68.2 0.575 2.61 0.38996 
Rv3676 14 28 534 356 115 32.8 45.2 0.725 3.89 0.58282 
Rv3736 287 682 396 100 123 55.6 45.6 0.844 0.45 0.18199 
Rv3765c 12 208 1166 1278 135 17.7 63.8 0.69 1.38 0.34529 
Rv3830c 102 944 418 157 123 52.2 52.1 0.459 2.39 0.3647 
Rv3849 228 114 380 226 462 31.1 48.4 0.636 1.47 0.24672 
Rv3862c 8 50 1258 956 280 6.9 68.8 0.783 0.67 0.1603 
Rv3911 4 29 311 70 144 -2.5 47.3 0.505 2.95 0.34529 
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Table 4. ChIPed TFs from E. coli. Table columns contain: TF name, ChIP information (number of enriched 
regions (after all filters are applied), normalized height of the best region, average width of regions, standard 
deviation of region widths, mean coverage in ChIP experiment), motif information (negative log10 e-value of de 
novo predicted motif). 
TF ChIP-stats Motif 
# regions max height avg width std width mean coverage -LOG10 eval 
allS 48 75 374 184 140 12.68 
cbl 18 90 264 74 156 8.28 
csgD 5 9 196 67 471 -0.08 
csiR 136 73 493 455 175 17.07 
dsdC 48 114 358 265 131 23.17 
fur 868 332 277 123 74 30.89 
gadW 3 348 702 408 445 -2.23 
lrhA 197 442 344 203 138 24.22 
mntR 230 424 258 95 147 37.7 
nac 585 851 267 97 127 31.08 
ntrC 62 1622 472 289 86 18.3 
ompR 52 148 388 188 364 38.31 
rtcR 66 199 371 315 415 -1.15 
stpA 474 70 854 959 342 53.08 
torR 32 132 330 152 174 14.26 
treR 4 79 466 357 128 0.77 
uxuR 280 664 476 477 378 17.46 
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